Difference between revisions of "Template:Glutamate receptor modulators"

From blackwiki
Jump to navigation Jump to search
imported>Anypodetos
m (Simplify markup, replaced:  • →  • (236), <br> → <br /> using AWB)
Line 13: Line 13:
  
 
     | group2 = [[NMDA receptor|NMDA]]
 
     | group2 = [[NMDA receptor|NMDA]]
     | list2  = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]&nbsp;•  [[Glutamate]]&nbsp;•  [[Homoquinolinic acid]]&nbsp;•  [[Ibotenic acid]]&nbsp;•  [[NMDA]]&nbsp;•  [[Quinolinic acid]]&nbsp;•  [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]&nbsp;•  [[ACPC]]&nbsp;•  [[ACPD]]&nbsp;•  [[Alanine]]&nbsp;•  [[Carboxycyclopropylglycine|CCG]]&nbsp;•  [[Cycloserine]]&nbsp;•  [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]&nbsp;•  [[Fluoroalanine]]&nbsp;•  [[Glycine]]&nbsp;•  [[HA-966]]&nbsp;•  [[L-687,414]]&nbsp;•  [[Milacemide]]&nbsp;•  [[Sarcosine]]&nbsp;•  [[Serine]]&nbsp;•  [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]&nbsp;•  [[Spermidine]]&nbsp;•  [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]&nbsp;•  [[AP-7 (drug)|AP7]]&nbsp;•  [[CGP-37849]]&nbsp;•  [[CGP-39551]]&nbsp;•  [[CGP-39653]]&nbsp;•  [[CGP-40116]]&nbsp;•  [[CGS-19755]]&nbsp;•  [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]&nbsp;•  [[LY-233,053]]&nbsp;•  [[LY-235,959]]&nbsp;•  [[LY-274,614]]&nbsp;•  [[MDL-100,453]]&nbsp;•  [[Midafotel|Midafotel (d-CPPene)]]&nbsp;•  [[NPC-12,626]]&nbsp;•  [[NPC-17,742]]&nbsp;•  [[PBPD]]&nbsp;•  [[PEAQX]]&nbsp;•  [[Perzinfotel]]&nbsp;•  [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]&nbsp;•  [[SDZ-220581]]&nbsp;•  [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]&nbsp;•  [[Caroverine]]&nbsp;•  [[Dexanabinol]]&nbsp;•  [[FPL-12495]]&nbsp;•  [[FR-115,427]]&nbsp;•  [[Hodgkinsine]]&nbsp;•  [[Magnesium]]&nbsp;•  [[MDL-27,266]]&nbsp;•  [[NPS-1506]]&nbsp;•  [[Psychotridine]]&nbsp;•  [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]&nbsp;•  [[3-MeO-PCP]]&nbsp;•  [[8a-Phenyldecahydroquinoline|8A-PDHQ]]&nbsp;•  [[Amantadine]]&nbsp;•  [[Aptiganel]]&nbsp;•  [[ARL-12,495]]&nbsp;•  [[ARL-15,896-AR]]&nbsp;•  [[ARL-16,247]]&nbsp;•  [[Budipine]]&nbsp;•  [[Delucemine]]&nbsp;•  [[Dexoxadrol]]&nbsp;•  [[Dextrallorphan]]&nbsp;•  [[Dieticyclidine]]&nbsp;•  [[Dizocilpine]]&nbsp;•  [[Endopsychosin]]&nbsp;•  [[Esketamine]]&nbsp;•  [[Etoxadrol]]&nbsp;•  [[Eticyclidine]]&nbsp;•  [[Gacyclidine]]&nbsp;•  [[Ibogaine]]&nbsp;•  [[Indantadol]]&nbsp;•  [[Ketamine]]&nbsp;•  [[Ketobemidone]]&nbsp;•  [[Loperamide]]&nbsp;•  [[Memantine]]&nbsp;•  [[Meperidine|Meperidine (Pethidine)]]&nbsp;•  [[Methadone]]&nbsp;•  [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]])&nbsp;•  [[Methoxetamine]]&nbsp;•  [[Milnacipran]]&nbsp;•  [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]])&nbsp;•  [[NEFA (drug)|NEFA]]&nbsp;•  [[Neramexane]]&nbsp;•  [[Nitrous oxide]]&nbsp;•  [[Noribogaine]]&nbsp;•  [[Orphenadrine]]&nbsp;•  [[PCPr]]&nbsp;•  [[Phencyclamine]]&nbsp;•  [[Phencyclidine]]&nbsp;•  [[Propoxyphene]]&nbsp;•  [[Remacemide]]&nbsp;•  [[Rhynchophylline]]&nbsp;•  [[Riluzole]]&nbsp;•  [[Rimantadine]]&nbsp;•  [[Rolicyclidine]]&nbsp;•  [[Sabeluzole]]&nbsp;•  [[Tenocyclidine]]&nbsp;•  [[Tiletamine]]&nbsp;•  [[Tramadol]]&nbsp;•  [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]&nbsp;•  [[ACEA-1328]]&nbsp;•  [[1-Aminocyclopropanecarboxylic acid|ACPC]]&nbsp;•  [[Carisoprodol]]&nbsp;•  [[CGP-39653]]&nbsp;•  [[7-Chlorokynurenate|CKA]]&nbsp;•  [[DCKA]]&nbsp;•  [[Felbamate]]&nbsp;•  [[Gavestinel]]&nbsp;•  [[GV-196,771]]&nbsp;•  [[Kynurenic acid]]&nbsp;•  [[L-689,560]]&nbsp;•  [[L-701,324]]&nbsp;•  [[Lacosamide]]&nbsp;•  [[Licostinel]]&nbsp;•  [[LU-73,068]]&nbsp;•  [[MDL-105,519]]&nbsp;•  [[Meprobamate]]&nbsp;•  [[MRZ 2/576]]&nbsp;•  [[PNQX]]&nbsp;•  [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]&nbsp;•  [[CO-101,244|CO-101,244 (PD-174,494)]]&nbsp;•  [[CP-101,606]]&nbsp;•  [[Eliprodil]]&nbsp;•  [[Haloperidol]]&nbsp;•  [[Ifenprodil]]&nbsp;•  [[Isoxsuprine]]&nbsp;•  [[Nylidrin]]&nbsp;•  [[Ro8-4304]]&nbsp;•  [[Ro25-6981]]&nbsp;•  [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]&nbsp;•  [[Co 101676]]&nbsp;•  [[1,3-Diaminopropane|Diaminopropane]]&nbsp;• [[Diethylenetriamine]]&nbsp;•  [[Huperzine A]]&nbsp;•  [[Putrescine]]&nbsp;•  [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]&nbsp;•  [[Diethyl ether]]&nbsp;•  [[Enflurane]]&nbsp;•  [[Ethanol|Ethanol (Alcohol)]]&nbsp;•  [[Halothane]]&nbsp;•  [[Isoflurane]]&nbsp;•  [[Methoxyflurane]]&nbsp;•  [[Toluene]]&nbsp;•  [[1,1,1-Trichloroethane|Trichloroethane]]&nbsp;•  [[2,2,2-Trichloroethanol|Trichloroethanol]]&nbsp;•  [[Trichloroethylene]]&nbsp;•  [[Xylene]]
+
     | list2  = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]&nbsp;•  [[Glutamate]]&nbsp;•  [[Homoquinolinic acid]]&nbsp;•  [[Ibotenic acid]]&nbsp;•  [[NMDA]]&nbsp;•  [[Quinolinic acid]]&nbsp;•  [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]&nbsp;•  [[ACPC]]&nbsp;•  [[ACPD]]&nbsp;•  [[Alanine]]&nbsp;•  [[Carboxycyclopropylglycine|CCG]]&nbsp;•  [[Cycloserine]]&nbsp;•  [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]&nbsp;•  [[Fluoroalanine]]&nbsp;•  [[Glycine]]&nbsp;•  [[HA-966]]&nbsp;•  [[L-687,414]]&nbsp;•  [[Milacemide]]&nbsp;•  [[Sarcosine]]&nbsp;•  [[Serine]]&nbsp;•  [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]&nbsp;•  [[Spermidine]]&nbsp;•  [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]&nbsp;•  [[AP-7 (drug)|AP7]]&nbsp;•  [[CGP-37849]]&nbsp;•  [[CGP-39551]]&nbsp;•  [[CGP-39653]]&nbsp;•  [[CGP-40116]]&nbsp;•  [[CGS-19755]]&nbsp;•  [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]&nbsp;•  [[LY-233,053]]&nbsp;•  [[LY-235,959]]&nbsp;•  [[LY-274,614]]&nbsp;•  [[MDL-100,453]]&nbsp;•  [[Midafotel|Midafotel (d-CPPene)]]&nbsp;•  [[NPC-12,626]]&nbsp;•  [[NPC-17,742]]&nbsp;•  [[PBPD]]&nbsp;•  [[PEAQX]]&nbsp;•  [[Perzinfotel]]&nbsp;•  [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]&nbsp;•  [[SDZ-220581]]&nbsp;•  [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]&nbsp;•  [[Caroverine]]&nbsp;•  [[Dexanabinol]]&nbsp;•  [[FPL-12495]]&nbsp;•  [[FR-115,427]]&nbsp;•  [[Hodgkinsine]]&nbsp;•  [[Magnesium]]&nbsp;•  [[MDL-27,266]]&nbsp;•  [[NPS-1506]]&nbsp;•  [[Psychotridine]]&nbsp;•  [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]&nbsp;•  [[3-MeO-PCP]]&nbsp;•  [[8a-Phenyldecahydroquinoline|8A-PDHQ]]&nbsp;•  [[Amantadine]]&nbsp;•  [[Aptiganel]]&nbsp;•  [[ARL-12,495]]&nbsp;•  [[ARL-15,896-AR]]&nbsp;•  [[ARL-16,247]]&nbsp;•  [[Budipine]]&nbsp;•  [[Delucemine]]&nbsp;•  [[Dexoxadrol]]&nbsp;•  [[Dextrallorphan]]&nbsp;•  [[Dieticyclidine]]&nbsp;•  [[Dizocilpine]]&nbsp;•  [[Endopsychosin]]&nbsp;•  [[Esketamine]]&nbsp;•  [[Etoxadrol]]&nbsp;•  [[Eticyclidine]]&nbsp;•  [[Gacyclidine]]&nbsp;•  [[Ibogaine]]&nbsp;•  [[Indantadol]]&nbsp;•  [[Ketamine]]&nbsp;•  [[Ketobemidone]]&nbsp;•  [[Loperamide]]&nbsp;•  [[Memantine]]&nbsp;•  [[Meperidine|Meperidine (Pethidine)]]&nbsp;•  [[Methadone]]&nbsp;•  [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]])&nbsp;•  [[Methoxetamine]]&nbsp;•  [[Milnacipran]]&nbsp;•  [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]])&nbsp;•  [[NEFA (drug)|NEFA]]&nbsp;•  [[Neramexane]]&nbsp;•  [[Nitrous oxide]]&nbsp;•  [[Noribogaine]]&nbsp;•  [[Orphenadrine]]&nbsp;•  [[PCPr]]&nbsp;•  [[Phencyclamine]]&nbsp;•  [[Phencyclidine]]&nbsp;•  [[Propoxyphene]]&nbsp;•  [[Remacemide]]&nbsp;•  [[Rhynchophylline]]&nbsp;•  [[Riluzole]]&nbsp;•  [[Rimantadine]]&nbsp;•  [[Rolicyclidine]]&nbsp;•  [[Sabeluzole]]&nbsp;•  [[Tenocyclidine]]&nbsp;•  [[Tiletamine]]&nbsp;•  [[Tramadol]]&nbsp;•  [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]&nbsp;•  [[ACEA-1328]]&nbsp;•  [[1-Aminocyclopropanecarboxylic acid|ACPC]]&nbsp;•  [[Carisoprodol]]&nbsp;•  [[CGP-39653]]&nbsp;•  [[7-Chlorokynurenate|CKA]]&nbsp;•  [[DCKA]]&nbsp;•  [[Felbamate]]&nbsp;•  [[Gavestinel]]&nbsp;•  [[GV-196,771]]&nbsp;•  [[Kynurenic acid]]&nbsp;•  [[L-689,560]]&nbsp;•  [[L-701,324]]&nbsp;•  [[Lacosamide]]&nbsp;•  [[Licostinel]]&nbsp;•  [[LU-73,068]]&nbsp;•  [[MDL-105,519]]&nbsp;•  [[Meprobamate]]&nbsp;•  [[MRZ 2/576]]&nbsp;•  [[PNQX]]&nbsp;•  [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]&nbsp;•  [[CO-101,244|CO-101,244 (PD-174,494)]]&nbsp;•  [[CP-101,606]]&nbsp;•  [[Eliprodil]]&nbsp;•  [[Haloperidol]]&nbsp;•  [[Ifenprodil]]&nbsp;•  [[Isoxsuprine]]&nbsp;•  [[Nylidrin]]&nbsp;•  [[Ro8-4304]]&nbsp;•  [[Ro25-6981]]&nbsp;•  [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]&nbsp;•  [[Co 101676]]&nbsp;•  [[1,3-Diaminopropane|Diaminopropane]]&nbsp;• [[Acamprosate]]&nbsp;• [[Diethylenetriamine]]&nbsp;•  [[Huperzine A]]&nbsp;•  [[Putrescine]]&nbsp;•  [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]&nbsp;•  [[Diethyl ether]]&nbsp;•  [[Enflurane]]&nbsp;•  [[Ethanol|Ethanol (Alcohol)]]&nbsp;•  [[Halothane]]&nbsp;•  [[Isoflurane]]&nbsp;•  [[Methoxyflurane]]&nbsp;•  [[Toluene]]&nbsp;•  [[1,1,1-Trichloroethane|Trichloroethane]]&nbsp;•  [[2,2,2-Trichloroethanol|Trichloroethanol]]&nbsp;•  [[Trichloroethylene]]&nbsp;•  [[Xylene]]
  
 
     | group3 = [[Kainate receptor|Kainate]]
 
     | group3 = [[Kainate receptor|Kainate]]

Revision as of 16:49, 11 March 2011